2.30. Analysis.
Comparison 2 Rivastigmine oral capsules (1 to 4 mg/day or 6 to 12 mg/day in two divided doses) versus placebo, Outcome 30 at least one adverse event of headache by 26 weeks.
Comparison 2 Rivastigmine oral capsules (1 to 4 mg/day or 6 to 12 mg/day in two divided doses) versus placebo, Outcome 30 at least one adverse event of headache by 26 weeks.